Lord & Richards Wealth Management LLC Purchases New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Lord & Richards Wealth Management LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 527 shares of the medical equipment provider's stock, valued at approximately $261,000.

Other large investors have also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $2,401,493,000. GAMMA Investing LLC lifted its stake in Intuitive Surgical by 54,010.7% in the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after purchasing an additional 3,022,979 shares during the last quarter. Capital Research Global Investors boosted its position in Intuitive Surgical by 25.5% in the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after buying an additional 687,906 shares in the last quarter. Northern Trust Corp boosted its position in Intuitive Surgical by 15.8% in the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after buying an additional 494,496 shares in the last quarter. Finally, Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after buying an additional 360,591 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and cut their price objective for the company from $515.00 to $440.00 in a report on Monday, June 9th. Evercore ISI lifted their price target on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Royal Bank Of Canada reduced their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. BTIG Research set a $566.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a report on Monday. Finally, Piper Sandler cut their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $592.86.

Insider Transactions at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director directly owned 6,371 shares in the company, valued at $3,312,920. This trade represents a 27.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,998 shares of company stock valued at $2,611,577 in the last 90 days. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded down $4.21 on Tuesday, reaching $512.23. 1,673,183 shares of the company's stock were exchanged, compared to its average volume of 1,684,092. The firm's 50-day moving average is $537.54 and its two-hundred day moving average is $536.54. The company has a market capitalization of $183.59 billion, a P/E ratio of 75.11, a price-to-earnings-growth ratio of 5.43 and a beta of 1.64. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same quarter in the prior year, the business earned $1.50 earnings per share. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.